DO
PTCT icon

denkapparat Operations’s PTC Therapeutics PTCT Stock Holding History

denkapparat Operations’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Hold
3,290
– – 0.09% 340
2026
Q1 		$224K Sell
3,290
-2,668
-45% -$189K 0.09% 309
2025
Q4 		$453K Hold
5,958
– – 0.25% 163
2025
Q3 		$366K Buy
+5,958
New +$310K 0.23% 169

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

denkapparat Operations's PTCT Position: Q2 2026 in Review

denkapparat Operations held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 3,290 shares worth $268K. The position accounts for 0.09% of the portfolio, ranked #340.

denkapparat Operations first reported a position in PTCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $453K in Q4 2025. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • denkapparat Operations held 3,290 shares of PTC Therapeutics worth $268K as of Q2 2026.
  • denkapparat Operations left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up 0.09% of denkapparat Operations's portfolio in Q2 2026, its #340 holding.
  • denkapparat Operations first reported a position in PTC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • denkapparat Operations's PTC Therapeutics position peaked at $453K in Q4 2025.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.